Taking into account the fact that the molecules of various organophosphorus compounds could interact with decarboxylases, as we have established earlier in silico, leading to the inhibition of these enzymes and to the development of a number of neurodegenerative diseases [62], it can be assumed that the His6-OPH/Lfcin combination could be used as a potential antidote in the prevention of the development of neurodegenerative diseases. The gene discussed is APEH; the disease is neurodegenerative disease.